Healthcare, Pharma & Life Sciences

Pittsburgh – October 15, 2026 -- Allegheny Health Network (AHN) has appointed surgical oncologist Nipun B. Merchant, MD, as chair of its Department of Surgery and its first surgeon-in-chief, effective February 2027.

New surgeon-in-chief role centralizes oversight of network surgery

The newly created position makes Merchant the senior physician executive for AHN's surgical enterprise, with strategic oversight of surgical services across the network's hospitals and ambulatory surgery centers. As chair, he will lead the department's clinical, academic and strategic growth, including faculty recruitment, expansion of advanced surgical programs, education and research. He will work with physicians, nurses and operational leaders on quality, safety and patient experience.

AHN says the role reflects a push toward a more integrated model of surgical care across its growing network.

Woonsocket – October 15, 2026 -- CVS Health's MinuteClinic has earned its seventh consecutive Joint Commission Ambulatory Health Care Accreditation, covering more than 800 locations nationwide and MinuteClinic Virtual Care, and for the first time the survey assessed its primary care sites under Medical Center standards.

Approximately 80 percent of the locations surveyed offer primary care and were evaluated under those standards. More than 65 percent of all MinuteClinic locations now offer primary care to patients 18 and older through health system and payer affiliations.

Greenwich – October 15, 2026 -- WIN, a fertility and family support benefit company, has appointed three senior leaders to newly created roles as its supported population grows from more than 500,000 to nearly one million families over two years.

Claudio Stefan joins as Chief Growth Officer, Stacey Zeltner as Chief People Officer, and Dr. Michael Meighu as Vice President of Artificial Intelligence. The company says the hires will help it scale employer and health plan partnerships, build the organization to support that growth, and apply emerging technology to benefits delivery.

WIN reports 900 employer clients covering 9.5 million lives

The employer base has grown 20% in two years. WIN also expanded from 55 to 124 countries, a 125% increase.

Tucson – October 15, 2026 -- Siensmetrica, Inc. has changed its name to Tessa AI, Inc. effective October 7, aligning the company with the brand of its AI research evaluation platform, Tessa, and signaling a push beyond paper scoring into tools for the full lifecycle of scientific research.

Tessa AI has served biomedical users since a May 2026 launch

Since its May 2026 launch, the Tessa platform has been used by researchers, clinicians, and biopharma professionals to evaluate biomedical studies. Each score comes with the evidence behind it. The company said customers, partners, and its own team already called it Tessa.

The former name was a coined word meaning roughly "knowledge measurement," reflecting the company's origin as a system for scoring published research. Siensmetrica.com now redirects to tessaai.co.

Oxford – October 15, 2026 -- Brainomix has partnered with the Pulmonary Fibrosis Foundation (PFF) to test how patients and caregivers respond when its FDA-cleared, CE-marked e-Lung quantitative CT analysis is built into clinicians' assessment workflow for pulmonary fibrosis (PF) and other fibrotic interstitial lung diseases (ILD).

Patient research targets how CT metrics shape treatment conversations

The multi-phase initiative will examine how objective quantitative CT metrics could improve clinicians' understanding of disease change over time. It will also assess how patients experience and understand those insights.

Toronto – October 14, 2026 -- Real-world discontinuation of weight-loss medications can reach 67% within 12 months, while clinical trials show sustained weight reduction of 15–22% over 72 weeks, according to materials for an Xtalks webinar featuring Clinical ink executives on October 29.

Psychology, not only side effects, drives discontinuation of obesity therapy

Side effects, cost and access explain only part of the drop-off, the organizers state. Confidence, doubt and treatment identity are increasingly recognized as independent predictors of discontinuation. Motivations differ by patient, rooted in appearance, day-to-day function or long-term health risk.

Most patient support programs have no validated way to identify behavioral risk before it affects outcomes, creating a gap for pharma teams managing obesity portfolios.

Atlanta – October 14, 2026 -- Solv Wellness, a women's health company focused on perimenopause and menopause, has appointed Christine Vaccaro, DO, FACOG, MSCP, as its first Chief Medical Officer, effective immediately.

Vaccaro will advise the company on its menopause education strategy and support educational initiatives for patients and healthcare professionals. She will also contribute to patient and clinician resources and represent the company in select media, speaking and educational programs.

Appointment targets a documented menopause education gap

The company cites two data points behind the move. Fewer than one in three U.S. OB/GYN residency programs offer a dedicated menopause curriculum, according to a 2023 study in the journal Menopause. Only about half of women going through menopause have consulted a health professional about it, according to a 2024 AARP survey.

Scottsdale – – October 14, 2026 -- Senior Helpers has given its highest honor, the Founders Award, to multi-unit franchisees Tiffany and Shaun Phelan, the first couple to receive it, for operating four locations across Arizona and California.

The Phelans own two locations in Scottsdale and Mesa, Arizona, and two in Clovis and Visalia, California. The award goes to owners who champion the brand's programs, support fellow owners and earn the trust of families in their communities. Senior Helpers presented it at its recent annual conference.

Shaun Phelan opened the first Senior Helpers franchise in 2007 and is the longest-tenured owner

Shaun Phelan opened the Scottsdale location in 2007. Tiffany joined the corporate team that same year before opening her first location in the Fresno area. She now leads dementia training for family caregivers and firefighters in California and Arizona. All four locations serve veterans through VA contracts.

Bridgewater, N.J. – – October 14, 2026 -- Insmed (Nasdaq: INSM) will present four abstracts on its investigational inhaled therapy treprostinil palmitil inhalation powder (TPIP) at CHEST 2026 in Phoenix, three of them late-breaking, and two ARIKAYCE abstracts at IDWeek 2026 in Washington, D.C. CHEST runs Oct. 18–21 and IDWeek runs Oct. 21–24.

Chief Medical Officer Martina Flammer said the presentations span the company's respiratory portfolio of BRINSUPRI, TPIP and ARIKAYCE.

Dallas – October 14, 2026 -- Nanoscope Therapeutics has appointed Troy Short, who built the global supply chain for Zolgensma across more than 30 countries at AveXis, as Senior Vice President of Manufacturing and Supply Chain while its lead gene therapy MOGENRY is under regulatory review in the United States and Japan.

Short takes charge of GMP manufacturing, commercial supply and global distribution

Short will lead Nanoscope's GMP manufacturing, commercial supply and global distribution strategy as the company moves toward potential approval and launch of MOGENRY (sonpiretigene isteparvovec; MCO-010). He has more than 20 years of operations and supply chain experience in pharmaceuticals and gene therapy.

His stated priorities are strengthening manufacturing partnerships, building a resilient commercial supply chain and ensuring product availability to patients and physicians upon potential approval.